论文部分内容阅读
Background Treatment of drug-eluting stent in-stent restenosis (DES-ISR) is still challenging especially in diffuse lesions.The intention of this subgroup analysis is to compare the safety and effectiveness of paclitaxel-coated balloon (PCB) versus paclitaxel-eluting stent (PES) in the treatment of patients with diffuse DES-ISR.